Log In
BCIQ
Print this Print this
 

VDC2008

  Manage Alerts
Collapse Summary General Information
Company Bostwick Laboratories Inc.
DescriptionIntratumoral injection of patient's own immature dendritic cells obtained from blood-borne precursors
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I/II
Standard IndicationProstate cancer
Indication DetailsTreat metastatic androgen-independent prostate cancer (AIPC)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today